Vice President of Growth & Engagement at CBS News and Stations Jennifer Earl is the Vice President of Growth & Engagement at CBS News and Stations. Jennifer has previously written for outlets ...

Regeneron Pharmaceuticals announced on Monday that it will acquire "substantially all" of genetic testing company 23andMe's assets. The pharmaceutical company said it won the court-supervised auction ...

SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (ME), a leading human genetics company, today announced the launch of Discover23®, a new research offering enabling ...

Regeneron Pharmaceuticals, a biotechnology company with a long history of large-scale genetics research, plans to buy DNA testing firm 23andMe out of bankruptcy, announcing Monday it was named the ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. The Sunnyvale, Calif.-based ...

Experts urge 23andMe costumers to delete their data after genetic company files for bankruptcy. Even if 23andMe costumers delete their data, the company will still retain some of your genetic ...

On March 23, 2025, genetic testing company 23andMe announced it filed for bankruptcy — sparking a firestorm of articles and online posts advising consumers to delete their personal data in order to ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. San Francisco-based 23andMe ...

Regeneron Pharmaceuticals acquiring genetic testing firm 23andMe for $256 million. The deal follows 23andMe’s Chapter 11 bankruptcy protection filing in March. Transaction excludes telehealth provider ...

Genetic testing company 23andMe filed for Chapter 11 bankruptcy protection to help the $50 million company sell itself, the company announced Sunday. 23andMe's saliva-based kits have been helping ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. Bay Area-based 23andMe ...

23andMe is helping collaborators better understand disease biology, identify novel targets, boost clinical trial success, and engage people in their care SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 ...